Abiomed Inc (ABMD) - Product Pipeline Analysis, 2018 Update

Abiomed Inc (ABMD) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME841PD
  • |
  • Pages: 39
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Abiomed Inc (Abiomed) is a provider of mechanical circulatory support devices. It develops, manufactures and markets novel technologies designed to replace or assist the pumping function in a failing heart. The company's heart support and recovery product portfolio includes catheters for circulatory support; minimally invasive implantable cardiac assist devices; and percutaneous catheter based devices including micro heart pumps, expandable catheter pumps and axial flow pumps. Abiomed also offers automated controllers, designed to control and monitor the catheter performance and display real time hemodynamic and catheter position information. It has manufacturing facilities in Danvers, Massachusetts; and Aachen, Germany. The company sells its products through direct sales and distributors in the Americas, Europe, Asia and the Middle East. Abiomed is headquartered in Danvers, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Abiomed Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market entry and market expansion strategies

Exploit in licensing and out licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Abiomed Inc Company Overview 5

Abiomed Inc Company Snapshot 5

Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Abiomed Inc Pipeline Analysis Overview 7

Business Description 7

Abiomed Inc Key Facts 8

Abiomed Inc Major Products and Services 9

Abiomed Inc Pipeline Products by Development Stage 10

Abiomed Inc Ongoing Clinical Trials by Trial Status 12

Abiomed Inc Pipeline Products Overview 14

AbioCor II 14

AbioCor II Product Overview 14

Impella BTR 15

Impella BTR Product Overview 15

Impella CP (Cardiac Power) 16

Impella CP (Cardiac Power) Product Overview 16

Impella CP (Cardiac Power) Clinical Trial 17

Impella ECP 18

Impella ECP Product Overview 18

Impella RP 19

Impella RP Product Overview 19

Impella RP Clinical Trial 20

Next Generation Impella CP STEMI 21

Next Generation Impella CP STEMI Product Overview 21

Next Generation Impella CP STEMI Clinical Trial 22

Symphony Heart Pump 23

Symphony Heart Pump Product Overview 23

Abiomed Inc Key Competitors 24

Abiomed Inc Key Employees 25

Abiomed Inc Key Employee Biographies 26

Abiomed Inc Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Abiomed Inc, Recent Developments 28

May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 28

Apr 12, 2018: First Patient Treated with High Energy Proton Therapy in UK 28

Apr 04, 2018: Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg 29

Apr 02, 2018: Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor 30

Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 31

Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 31

Feb 14, 2018: Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures 32

Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 33

Feb 13, 2018: Atossa Genetics to Present at Adoptive T Cell Therapy Symposium Molecular Medicine Tri Conference 34

Feb 13, 2018: Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock 35

Appendix 36

Methodology 36

About GlobalData 38

Contact Us 38

Disclaimer 39

List of Figures

Abiomed Inc Pipeline Products by Equipment Type 6

Abiomed Inc Pipeline Products by Development Stage 10

Abiomed Inc Ongoing Clinical Trials by Trial Status 12

List of Tables

Abiomed Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Abiomed Inc Pipeline Products by Equipment Type 6

Abiomed Inc Pipeline Products by Indication 6

Abiomed Inc Ongoing Clinical Trials by Trial Status 6

Abiomed Inc, Key Facts 8

Abiomed Inc, Major Products and Services 9

Abiomed Inc Number of Pipeline Products by Development Stage 10

Abiomed Inc Pipeline Products Summary by Development Stage 11

Abiomed Inc Ongoing Clinical Trials by Trial Status 12

Abiomed Inc Ongoing Clinical Trials Summary 13

AbioCor II Product Status 14

AbioCor II Product Description 14

Impella BTR Product Status 15

Impella BTR Product Description 15

Impella CP (Cardiac Power) Product Status 16

Impella CP (Cardiac Power) Product Description 16

Impella CP (Cardiac Power) A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry 17

Impella CP (Cardiac Power) Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial 17

Impella CP (Cardiac Power) Pulsecath mechanicaL Support Evaluation (PULSE) Trial 17

Impella ECP Product Status 18

Impella ECP Product Description 18

Impella RP Product Status 19

Impella RP Product Description 19

Impella RP A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry 20

Next Generation Impella CP STEMI Product Status 21

Next Generation Impella CP STEMI Product Description 21

Next Generation Impella CP STEMI Door to Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study 22

Symphony Heart Pump Product Status 23

Symphony Heart Pump Product Description 23

Abiomed Inc, Key Employees 25

Abiomed Inc, Key Employee Biographies 26

Abiomed Inc, Subsidiaries 27

Glossary 37

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Abbott Laboratories

Boston Scientific Corp

Edwards Lifesciences Corp

Getinge AB

HeartWare International Inc

Jarvik Heart Inc

Maquet Cardiovascular LLC

Medtronic Plc

TandemLife

Teleflex Inc

Terumo Heart, Inc.

Abiomed Inc,Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 51750
Site License
USD 1500 INR 103500
Corporate User License
USD 2250 INR 155250

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com